期刊文献+

参芪扶正注射液拮抗肺癌化疗毒副反应的成本分析 被引量:20

Cost analysis of Shenqi Fuzheng injection on reducing adverse effects during chemotherapy
原文传递
导出
摘要 目的 从经济学角度评价传统中药党参、黄芪提取物———参芪扶正注射液在肺癌患者化疗中的应用价值。方法 采用随机交叉试验设计 ,每个患者完成 2个化疗周期 ,试验周期使用参芪扶正注射液 ,对照周期不使用参芪扶正注射液。观察患者化疗毒副反应和化疗期间的生命质量 ,比较患者用于拮抗化疗毒副反应的直接成本并进行成本 效果分析。结果  1 30例纳入试验 ,完成 2个周期化疗 1 2 3例。加入参芪扶正注射液后患者化疗期间发生Ⅲ级以上严重白细胞减少、血小板减少和呕吐反应人数明显减少 ,生命质量的多项维度明显改善 ,成本 效果分析明显优于对照未使用参芪扶正注射液的对照周期。结论 参芪扶正注射液能够明显降低化疗期间常见毒副反应的发生率 ,改善患者化疗期间的生命质量 ,具有一定的成本 Objective The goals of this work was to analyse the cost of Shenqi Fuzheng injection an extraction of a Chinese traditional herbs on reducing adverse effects in lung cancer patients during chemotherapy. Methods In a randomized cross over trial, each patient completed two identical cisplatin based chemotherapy cycles, one with Shenqi Fuzheng injection, another without Shenqi Fuzheng injection. Adverse effects and change scores of quality of life (QOL) during chemotherapy were compared in tow cycles. The direct cost dealed with adverse effect and cost effectiveness analysis were taken. Results One hundred and thirty were enrolled with 123 of whom were evaluable. The patient characteristics were well balanced between the two groups. The chemotherapy cycles with Shenqi Fuzheng injection spent 220.5 more Chinese yuan, but the adverse effect of leukopenia, thrombocytopenia and vomiting were slight different and the change of score of several QOL domains showed singnigicant better as comparerd to those in another cycle. Conclusion Shenqi Fuzheng injection could reduce the severity of toxicity related to chemotherapy and improve the QOL of patients and had some benefits in terms of cost effectiveness.
出处 《中华流行病学杂志》 CAS CSCD 北大核心 2003年第2期130-134,共5页 Chinese Journal of Epidemiology
基金 国际临床流行病学网络 (INCLEN)资助项目
关键词 参芪扶正注射液 肺癌 化疗 药物疗法 毒副反应 成本分析 Shenqi Fuzheng injection Lung neoplasms Chemotherapy Cost effectiveness analysis Cross over design
  • 相关文献

参考文献2

  • 1王家良.临床流行病学:第2版[M].上海:上海科学技术出版社,2001..
  • 2国家中医药管理局.中药现代研究与临床应用:第1版[M].北京:人民卫生出版社,1995.55-67.

共引文献2

同被引文献210

引证文献20

二级引证文献126

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部